FDA label c47f2d23-f2d7-43ad-899c-356d3b3dabfd

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
70714f21-5a4a-4ed3-8cda-5c271bd2c594
SPL ID
c47f2d23-f2d7-43ad-899c-356d3b3dabfd
Version
1
Effective date
2012-08-17
Source export date
2026-11-13
Source partition
10
Source file
https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/829e43b83940afb8dda22d5287c5b17e57d3fe45d1157678854b4f9b7ad07271/drug-label-0010-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 17:21:51

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 2 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions have been reported with Hydrocortisone Acetate Suppositories: 1. Burning 2. Itching 3. Irritation 4. Dryness 5. Folliculitis 6. Hypopigmentation 7. Allergic Contact Dermatitis 8. Secondary Infection

adverse reactions table

<table width="75%" styleCode="Noautorules"> <col width="50%" align="left" valign="top"/> <col width="50%" align="left" valign="top"/> <tbody> <tr> <td> <list listType="unordered"> <item> <caption>1.</caption>Burning</item> <item> <caption>2.</caption>Itching</item> <item> <caption>3.</caption>Irritation</item> <item> <caption>4.</caption>Dryness</item> </list> </td> <td> <list listType="unordered"> <item> <caption>5.</caption>Folliculitis</item> <item> <caption>6.</caption>Hypopigmentation</item> <item> <caption>7.</caption>Allergic Contact Dermatitis</item> <item> <caption>8.</caption>Secondary Infection</item> </list> </td> </tr> </tbody> </table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.